ACP-211

N/A

Report date: 2025/12/17 20:02:10
NME

Base Information

Drug NameACP-211
Drug Alias NameACP-211
ClassificationOther
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcadia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcadia Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A